Signet Financial Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $279K | Buy |
4,351
+164
| +4% | +$10.5K | 0.04% | 249 |
|
|
2025
Q1 | $266K | Sell |
4,187
-175
| -4% | -$11.1K | 0.04% | 245 |
|
|
2024
Q4 | $290K | Sell |
4,362
-56
| -1% | -$3.73K | 0.04% | 232 |
|
|
2024
Q3 | $308K | Sell |
4,418
-70
| -2% | -$4.89K | 0.04% | 227 |
|
|
2024
Q2 | $291K | Sell |
4,488
-13
| -0.3% | -$843 | 0.04% | 225 |
|
|
2024
Q1 | $291K | Sell |
4,501
-80
| -2% | -$5.18K | 0.04% | 229 |
|
|
2023
Q4 | $302K | Sell |
4,581
-487
| -10% | -$32.1K | 0.05% | 224 |
|
|
2023
Q3 | $289K | Buy |
5,068
+7
| +0.1% | +$399 | 0.05% | 222 |
|
|
2023
Q2 | $310K | Buy |
5,061
+35
| +0.7% | +$2.15K | 0.05% | 226 |
|
|
2023
Q1 | $315K | Buy |
+5,026
| New | +$315K | 0.05% | 223 |
|
|
2016
Q1 | – | Sell |
-3,981
| Closed | -$201K | – | 198 |
|
|
2015
Q4 | $201K | Sell |
3,981
-1,850
| -32% | -$93.4K | 0.04% | 188 |
|
|
2015
Q3 | $267K | Buy |
5,831
+1,169
| +25% | +$53.5K | 0.06% | 146 |
|
|
2015
Q2 | $272K | Buy |
+4,662
| New | +$272K | 0.06% | 149 |
|